References
- McCabe SE, Veliz P, Boyd CJ, Schulenberg JE. Medical and nonmedical use of prescription sedatives and anxiolytics: adolescents’ use and substance use disorder symptoms in adulthood. Addict Behav. 2017;65:296–301. doi:https://doi.org/10.1016/j.addbeh.2016.08.021..
- Maust DT, Blow FC, Wiechers IR, Kales HC, Marcus SC. National trends in antidepressant, benzodiazepine, and other sedative-hypnotic treatment of older adults in psychiatric and primary care. J Clin Psychiatry. 2017;78(04):e363–e71. doi:https://doi.org/10.4088/JCP.16m10713.
- Palamar JJ, Han BH, Martins SS. Shifting characteristics of nonmedical prescription tranquilizer users in the United States, 2005–2014. Drug Alcohol Depend. 2019;195:1–5. doi:https://doi.org/10.1016/j.drugalcdep.2018.11.015.
- Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: results from the 2018 National survey on drug use and health (HHS Publication No. SMA 19-5068, NSDUH Series H-54). Rockville (MD): Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2019. https://www.samhsa.gov/data/.
- Hollingworth SA, Siskind DJ. Anxiolytic, hypnotic and sedative medication use in Australia. Pharmacoepidemiol Drug Saf. 2010;19(3):280–8. doi:https://doi.org/10.1002/pds.1899..
- Lin CC, Bai YM, Hu PG, Yeh HS. Substance use disorders among inpatients with bipolar disorder and major depressive disorder in a general hospital. Gen Hosp Psychiatry. 1998;20(2):98–101. doi:https://doi.org/10.1016/S0163-8343(98)00003-6.
- Harris MG, Burgess PM, Pirkis J, Siskind D, Slade T, Whiteford HA. Correlates of antidepressant and anxiolytic, hypnotic or sedative medication use in an Australian community sample. Aust N Z J Psychiatry. 2011;45(3):249–60. doi:https://doi.org/10.3109/00048674.2010.531459..
- Weaver MF. Prescription sedative misuse and abuse. Yale J Biol Med. 2015;88(3):247–56.
- Kassed CA, Levit KR, Hambrick MM. Hospitalizations related to drug abuse, 2005: statistical brief #39. Accessed 2/5/21. Healthcare cost and utilization project (HCUP) statistical briefs accessed 2/5/21. Rockville (MD): Agency for Health Care Quality and Research; PMCID: PMC4553644 PMID: 26339207. 2006.
- Westover AN, McBride S, Haley RW. Stroke in young adults who abuse amphetamines or cocaine: a population-based study of hospitalized patients. Arch Gen Psychiatry. 2007;64(4):495–502. doi:https://doi.org/10.1001/archpsyc.64.4.495..
- Frost MC, Matson TE, Tsui JI, Williams EC. Influence of comorbid drug use disorder on receipt of evidence-based treatment for alcohol use disorder among VA patients with alcohol use disorder and Hepatitis C and/or HIV. Drug Alcohol Depend. 2019;194:288–95. doi:https://doi.org/10.1016/j.drugalcdep.2018.10.008..
- Best MJ, Buller LT, Klika AK, Barsoum WK. Outcomes following primary total hip or knee arthroplasty in substance misusers. J Arthroplast. 2015;30(7):1137–41. doi:https://doi.org/10.1016/j.arth.2015.01.052.
- El–Serag HB, Kunik M, Richardson P, Rabeneck L. Psychiatric disorders among veterans with hepatitis C infection. Gastroenterology. 2002;123(2):476–82. doi:https://doi.org/10.1053/gast.2002.34750..
- Bhalla IP, Stefanovics EA, Rosenheck RA. Clinical epidemiology of single versus multiple substance use disorders: polysubstance use disorder. Med Care. 2017;55(Suppl 9,Suppl 2):S24–S32. doi:https://doi.org/10.1097/MLR.0000000000000731..
- Kraemer KL, McGinnis KA, Fiellin DA, Skanderson M, Gordon AJ, Robbins J, Zickmund S, Bryant K, Korthuis PT. Low levels of initiation, engagement, and retention in substance use disorder treatment including pharmacotherapy among HIV-infected and uninfected veterans. J Subst Abuse Treat. 2019;103:23–32. doi:https://doi.org/10.1016/j.jsat.2019.05.007.
- Peterson C, Xu L, Mikosz CA, Florence C, Mack KA. US hospital discharges documenting patient opioid use disorder without opioid overdose or treatment services, 2011–2015. J Subst Abuse Treat. 2018;92:35–9. doi:https://doi.org/10.1016/j.jsat.2018.06.008..
- HCUP Databases. Healthcare Cost and Utilization Project (HCUP). Overview of the Nationwide Inpatient Sample (NIS). Rockville (MD): Agency for Healthcare Research and Quality; Last modified 13 August 2018; 2018. http://www.hcup-us.ahrq.gov/nisoverview.jsp.
- Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613–9. doi:https://doi.org/10.1016/0895-4356(92)90133-8..
- Murthy VH. Ending the opioid epidemic - A call to action. N Engl J Med. 2016;375(25):2413–5. doi:https://doi.org/10.1056/NEJMp1612578..
- Singh JA, Cleveland JD. National U.S. time-trends in opioid use disorder hospitalizations and associated healthcare utilization and mortality. PLoS One. 2020;15(2):e0229174. doi:https://doi.org/10.1371/journal.pone.0229174.